Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.33 |
| ▸ | KMO | O15229 | 2/20 | 0.33 |
| ▸ | SYK | P43405 | 4/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.30 |
| ▸ | IDH1 | O75874 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19454737 | 0.82 | KMO (0.31) | KMO | |
| SCHEMBL19455749 | 0.77 | — | — | |
| SCHEMBL29607 | 0.76 | ADRB1 (0.38) | ADRB1TAS2R14KMOSYKLOXL2 | |
| SCHEMBL17610 | 0.73 | HDAC4 (0.38) | ADRB1TAS2R14KMOSYKIDH1 | |
| SCHEMBL1578122 | 0.70 | KMO (0.54) | TAS2R14KMOSYK | |
| SCHEMBL31537115 | 0.69 | TAS2R14 (0.42) | ADRB1TAS2R14KMOSYK | |
| SCHEMBL3714661 | 0.69 | SYK (0.45) | ADRB1TAS2R14KMOSYK | |
| SCHEMBL13837225 | 0.69 | SYK (0.45) | ADRB1TAS2R14KMOSYKLOXL2 | |
| SCHEMBL2873952 | 0.69 | ADRB1 (0.43) | ADRB1TAS2R14SYKLOXL2IDH1 | |
| SCHEMBL15102659 | 0.68 | ADRB1 (0.35) | ADRB1TAS2R14SYKLOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170294605-A1 | Iridium complex, method for manufacturing same, and organic light-emitting devices using same | AAC Technologies Pte. Ltd. (SG) | 2017-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170294605-A1 | Iridium complex, method for manufacturing same, and organic light-emitting devices using same | ORC3, ORMDL3, TYK2 | ADRB1 1073/4885TAS2R14 1731/4885KMO 278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.